Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trialTsong‐Hai Lee, Philip M. Bath, Joseph P. Broderick et al.|The Lancet|2019Cited by 271
Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trialJianwen Guo, Xiaoying Chen, Manli Wu et al.|The Lancet|2024Cited by 38
INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): study protocol for a randomized controlled trialLili Song, Fang Liu, Chen Chen et al.|Trials|2021Cited by 30
Effects of blood pressure lowering in relation to time in acute intracerebral haemorrhage: a pooled analysis of the four INTERACT trialsXia Wang, Xinwen Ren, Qiang Li et al.|The Lancet Neurology|2025Cited by 23
Efficacy and Safety of Chinese Herbal Medicine in Patients with Acute Intracerebral Hemorrhage: Protocol for a Randomized Placebo-Controlled Double-Blinded Multicenter TrialYang Zhao, Wanzhen Cui, Tingting Xie et al.|Cerebrovascular Diseases|2023Cited by 7